nodes	percent_of_prediction	percent_of_DWPC	metapath
Levosimendan—KCNJ8—coronary artery disease	0.456	0.608	CbGaD
Levosimendan—PDE3A—coronary artery disease	0.294	0.392	CbGaD
Levosimendan—TNNC1—cardiac ventricle—coronary artery disease	0.00349	0.0958	CbGeAlD
Levosimendan—TNNC1—myocardium—coronary artery disease	0.00328	0.0901	CbGeAlD
Levosimendan—KCNJ8—cardiac ventricle—coronary artery disease	0.00262	0.0719	CbGeAlD
Levosimendan—KCNJ8—myocardium—coronary artery disease	0.00246	0.0676	CbGeAlD
Levosimendan—TNNC1—heart—coronary artery disease	0.00229	0.0629	CbGeAlD
Levosimendan—TNNC1—cardiovascular system—coronary artery disease	0.00216	0.0593	CbGeAlD
Levosimendan—PDE3A—cardiac ventricle—coronary artery disease	0.00209	0.0574	CbGeAlD
Levosimendan—PDE3A—myocardium—coronary artery disease	0.00196	0.054	CbGeAlD
Levosimendan—TNNC1—cardiac atrium—coronary artery disease	0.00196	0.0538	CbGeAlD
Levosimendan—KCNJ8—heart—coronary artery disease	0.00172	0.0472	CbGeAlD
Levosimendan—TNNC1—blood—coronary artery disease	0.00171	0.0469	CbGeAlD
Levosimendan—KCNJ8—cardiovascular system—coronary artery disease	0.00162	0.0445	CbGeAlD
Levosimendan—KCNJ8—cardiac atrium—coronary artery disease	0.00147	0.0404	CbGeAlD
Levosimendan—KCNJ11—heart—coronary artery disease	0.0014	0.0385	CbGeAlD
Levosimendan—PDE3A—heart—coronary artery disease	0.00137	0.0377	CbGeAlD
Levosimendan—KCNJ11—cardiovascular system—coronary artery disease	0.00132	0.0363	CbGeAlD
Levosimendan—PDE3A—cardiovascular system—coronary artery disease	0.00129	0.0355	CbGeAlD
Levosimendan—PDE3A—cardiac atrium—coronary artery disease	0.00117	0.0322	CbGeAlD
Levosimendan—PDE3A—blood—coronary artery disease	0.00102	0.0281	CbGeAlD
Levosimendan—Angiopathy—Olmesartan—coronary artery disease	0.000406	0.00341	CcSEcCtD
Levosimendan—Constipation—Ticagrelor—coronary artery disease	0.000405	0.00341	CcSEcCtD
Levosimendan—Tachycardia—Acetylsalicylic acid—coronary artery disease	0.000404	0.0034	CcSEcCtD
Levosimendan—Cardiac disorder—Pravastatin—coronary artery disease	0.000399	0.00336	CcSEcCtD
Levosimendan—Angiopathy—Niacin—coronary artery disease	0.000396	0.00334	CcSEcCtD
Levosimendan—Mental disorder—Valsartan—coronary artery disease	0.000394	0.00331	CcSEcCtD
Levosimendan—Mental disorder—Olmesartan—coronary artery disease	0.000392	0.0033	CcSEcCtD
Levosimendan—Malnutrition—Valsartan—coronary artery disease	0.000391	0.00329	CcSEcCtD
Levosimendan—Malnutrition—Olmesartan—coronary artery disease	0.000389	0.00328	CcSEcCtD
Levosimendan—Diarrhoea—Penbutolol—coronary artery disease	0.000389	0.00327	CcSEcCtD
Levosimendan—Cardiac disorder—Trandolapril—coronary artery disease	0.000388	0.00326	CcSEcCtD
Levosimendan—Insomnia—Rosuvastatin—coronary artery disease	0.000386	0.00325	CcSEcCtD
Levosimendan—Cardiac disorder—Telmisartan—coronary artery disease	0.000381	0.00321	CcSEcCtD
Levosimendan—Malnutrition—Niacin—coronary artery disease	0.00038	0.0032	CcSEcCtD
Levosimendan—Angiopathy—Trandolapril—coronary artery disease	0.000379	0.00319	CcSEcCtD
Levosimendan—Dizziness—Penbutolol—coronary artery disease	0.000376	0.00316	CcSEcCtD
Levosimendan—Angiopathy—Telmisartan—coronary artery disease	0.000372	0.00313	CcSEcCtD
Levosimendan—Mental disorder—Trandolapril—coronary artery disease	0.000366	0.00308	CcSEcCtD
Levosimendan—Constipation—Rosuvastatin—coronary artery disease	0.000365	0.00307	CcSEcCtD
Levosimendan—Malnutrition—Trandolapril—coronary artery disease	0.000364	0.00306	CcSEcCtD
Levosimendan—Nervous system disorder—Fenofibrate—coronary artery disease	0.000363	0.00306	CcSEcCtD
Levosimendan—Tachycardia—Fenofibrate—coronary artery disease	0.000361	0.00304	CcSEcCtD
Levosimendan—Cardiac disorder—Perindopril—coronary artery disease	0.000359	0.00303	CcSEcCtD
Levosimendan—Mental disorder—Telmisartan—coronary artery disease	0.000359	0.00303	CcSEcCtD
Levosimendan—Malnutrition—Telmisartan—coronary artery disease	0.000357	0.00301	CcSEcCtD
Levosimendan—Nervous system disorder—Clopidogrel—coronary artery disease	0.000357	0.003	CcSEcCtD
Levosimendan—Headache—Penbutolol—coronary artery disease	0.000356	0.003	CcSEcCtD
Levosimendan—Angiopathy—Perindopril—coronary artery disease	0.000351	0.00296	CcSEcCtD
Levosimendan—Nervous system disorder—Ezetimibe—coronary artery disease	0.000348	0.00293	CcSEcCtD
Levosimendan—Hypotension—Fenofibrate—coronary artery disease	0.000346	0.00291	CcSEcCtD
Levosimendan—Angiopathy—Furosemide—coronary artery disease	0.000342	0.00288	CcSEcCtD
Levosimendan—Nervous system disorder—Eplerenone—coronary artery disease	0.00034	0.00286	CcSEcCtD
Levosimendan—Hypotension—Clopidogrel—coronary artery disease	0.00034	0.00286	CcSEcCtD
Levosimendan—Mental disorder—Perindopril—coronary artery disease	0.000339	0.00286	CcSEcCtD
Levosimendan—Nausea—Penbutolol—coronary artery disease	0.000338	0.00284	CcSEcCtD
Levosimendan—Malnutrition—Perindopril—coronary artery disease	0.000337	0.00284	CcSEcCtD
Levosimendan—Insomnia—Fenofibrate—coronary artery disease	0.000335	0.00282	CcSEcCtD
Levosimendan—Diarrhoea—Gemfibrozil—coronary artery disease	0.000332	0.00279	CcSEcCtD
Levosimendan—Angiopathy—Losartan—coronary artery disease	0.00033	0.00278	CcSEcCtD
Levosimendan—Insomnia—Clopidogrel—coronary artery disease	0.000329	0.00277	CcSEcCtD
Levosimendan—Malnutrition—Furosemide—coronary artery disease	0.000328	0.00276	CcSEcCtD
Levosimendan—Insomnia—Lovastatin—coronary artery disease	0.000327	0.00275	CcSEcCtD
Levosimendan—Hypotension—Eplerenone—coronary artery disease	0.000324	0.00273	CcSEcCtD
Levosimendan—Diarrhoea—Ticagrelor—coronary artery disease	0.000324	0.00273	CcSEcCtD
Levosimendan—Dizziness—Gemfibrozil—coronary artery disease	0.000321	0.0027	CcSEcCtD
Levosimendan—Insomnia—Ezetimibe—coronary artery disease	0.000321	0.0027	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Fenofibrate—coronary artery disease	0.000319	0.00269	CcSEcCtD
Levosimendan—Constipation—Fenofibrate—coronary artery disease	0.000316	0.00266	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Clopidogrel—coronary artery disease	0.000314	0.00264	CcSEcCtD
Levosimendan—Insomnia—Eplerenone—coronary artery disease	0.000314	0.00264	CcSEcCtD
Levosimendan—Dizziness—Ticagrelor—coronary artery disease	0.000313	0.00264	CcSEcCtD
Levosimendan—Nervous system disorder—Valsartan—coronary artery disease	0.000313	0.00264	CcSEcCtD
Levosimendan—Nervous system disorder—Olmesartan—coronary artery disease	0.000311	0.00262	CcSEcCtD
Levosimendan—Constipation—Clopidogrel—coronary artery disease	0.000311	0.00262	CcSEcCtD
Levosimendan—Tachycardia—Olmesartan—coronary artery disease	0.00031	0.00261	CcSEcCtD
Levosimendan—Constipation—Lovastatin—coronary artery disease	0.000309	0.0026	CcSEcCtD
Levosimendan—Vomiting—Gemfibrozil—coronary artery disease	0.000308	0.0026	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ezetimibe—coronary artery disease	0.000306	0.00258	CcSEcCtD
Levosimendan—Insomnia—Simvastatin—coronary artery disease	0.000306	0.00257	CcSEcCtD
Levosimendan—Headache—Gemfibrozil—coronary artery disease	0.000304	0.00256	CcSEcCtD
Levosimendan—Constipation—Ezetimibe—coronary artery disease	0.000303	0.00255	CcSEcCtD
Levosimendan—Tachycardia—Niacin—coronary artery disease	0.000303	0.00255	CcSEcCtD
Levosimendan—Vomiting—Ticagrelor—coronary artery disease	0.000301	0.00254	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Eplerenone—coronary artery disease	0.000299	0.00252	CcSEcCtD
Levosimendan—Hypotension—Valsartan—coronary artery disease	0.000298	0.00251	CcSEcCtD
Levosimendan—Hypotension—Olmesartan—coronary artery disease	0.000297	0.0025	CcSEcCtD
Levosimendan—Headache—Ticagrelor—coronary artery disease	0.000297	0.0025	CcSEcCtD
Levosimendan—Constipation—Eplerenone—coronary artery disease	0.000297	0.0025	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Simvastatin—coronary artery disease	0.000292	0.00246	CcSEcCtD
Levosimendan—Diarrhoea—Rosuvastatin—coronary artery disease	0.000292	0.00246	CcSEcCtD
Levosimendan—Nervous system disorder—Trandolapril—coronary artery disease	0.000291	0.00245	CcSEcCtD
Levosimendan—Hypotension—Niacin—coronary artery disease	0.00029	0.00244	CcSEcCtD
Levosimendan—Tachycardia—Trandolapril—coronary artery disease	0.00029	0.00244	CcSEcCtD
Levosimendan—Constipation—Simvastatin—coronary artery disease	0.000289	0.00243	CcSEcCtD
Levosimendan—Insomnia—Valsartan—coronary artery disease	0.000289	0.00243	CcSEcCtD
Levosimendan—Tachycardia—Enalapril—coronary artery disease	0.000288	0.00243	CcSEcCtD
Levosimendan—Nausea—Gemfibrozil—coronary artery disease	0.000288	0.00242	CcSEcCtD
Levosimendan—Insomnia—Olmesartan—coronary artery disease	0.000287	0.00242	CcSEcCtD
Levosimendan—Nervous system disorder—Telmisartan—coronary artery disease	0.000286	0.00241	CcSEcCtD
Levosimendan—Tachycardia—Telmisartan—coronary artery disease	0.000284	0.0024	CcSEcCtD
Levosimendan—Diarrhoea—Acetylsalicylic acid—coronary artery disease	0.000283	0.00239	CcSEcCtD
Levosimendan—Cardiac disorder—Timolol—coronary artery disease	0.000283	0.00238	CcSEcCtD
Levosimendan—Dizziness—Rosuvastatin—coronary artery disease	0.000282	0.00237	CcSEcCtD
Levosimendan—Nausea—Ticagrelor—coronary artery disease	0.000281	0.00237	CcSEcCtD
Levosimendan—Insomnia—Niacin—coronary artery disease	0.000281	0.00236	CcSEcCtD
Levosimendan—Hypotension—Trandolapril—coronary artery disease	0.000277	0.00233	CcSEcCtD
Levosimendan—Tachycardia—Captopril—coronary artery disease	0.000277	0.00233	CcSEcCtD
Levosimendan—Insomnia—Pravastatin—coronary artery disease	0.000276	0.00233	CcSEcCtD
Levosimendan—Angiopathy—Timolol—coronary artery disease	0.000276	0.00233	CcSEcCtD
Levosimendan—Hypotension—Enalapril—coronary artery disease	0.000276	0.00232	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Valsartan—coronary artery disease	0.000276	0.00232	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Olmesartan—coronary artery disease	0.000274	0.00231	CcSEcCtD
Levosimendan—Dizziness—Acetylsalicylic acid—coronary artery disease	0.000274	0.00231	CcSEcCtD
Levosimendan—Mental disorder—Ramipril—coronary artery disease	0.000273	0.0023	CcSEcCtD
Levosimendan—Constipation—Valsartan—coronary artery disease	0.000273	0.0023	CcSEcCtD
Levosimendan—Hypotension—Telmisartan—coronary artery disease	0.000272	0.00229	CcSEcCtD
Levosimendan—Constipation—Olmesartan—coronary artery disease	0.000272	0.00229	CcSEcCtD
Levosimendan—Malnutrition—Ramipril—coronary artery disease	0.000271	0.00228	CcSEcCtD
Levosimendan—Nervous system disorder—Perindopril—coronary artery disease	0.00027	0.00227	CcSEcCtD
Levosimendan—Tachycardia—Perindopril—coronary artery disease	0.000269	0.00226	CcSEcCtD
Levosimendan—Insomnia—Trandolapril—coronary artery disease	0.000268	0.00226	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Niacin—coronary artery disease	0.000268	0.00226	CcSEcCtD
Levosimendan—Insomnia—Enalapril—coronary artery disease	0.000267	0.00225	CcSEcCtD
Levosimendan—Headache—Rosuvastatin—coronary artery disease	0.000267	0.00225	CcSEcCtD
Levosimendan—Mental disorder—Timolol—coronary artery disease	0.000267	0.00225	CcSEcCtD
Levosimendan—Malnutrition—Timolol—coronary artery disease	0.000265	0.00223	CcSEcCtD
Levosimendan—Hypotension—Captopril—coronary artery disease	0.000265	0.00223	CcSEcCtD
Levosimendan—Insomnia—Telmisartan—coronary artery disease	0.000264	0.00222	CcSEcCtD
Levosimendan—Vomiting—Acetylsalicylic acid—coronary artery disease	0.000263	0.00222	CcSEcCtD
Levosimendan—Nervous system disorder—Furosemide—coronary artery disease	0.000262	0.00221	CcSEcCtD
Levosimendan—Constipation—Pravastatin—coronary artery disease	0.000261	0.0022	CcSEcCtD
Levosimendan—Hypotension—Perindopril—coronary artery disease	0.000257	0.00216	CcSEcCtD
Levosimendan—Insomnia—Captopril—coronary artery disease	0.000256	0.00216	CcSEcCtD
Levosimendan—Angiopathy—Lisinopril—coronary artery disease	0.000256	0.00216	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Trandolapril—coronary artery disease	0.000256	0.00216	CcSEcCtD
Levosimendan—Constipation—Trandolapril—coronary artery disease	0.000254	0.00214	CcSEcCtD
Levosimendan—Nausea—Rosuvastatin—coronary artery disease	0.000253	0.00213	CcSEcCtD
Levosimendan—Diarrhoea—Fenofibrate—coronary artery disease	0.000253	0.00213	CcSEcCtD
Levosimendan—Nervous system disorder—Losartan—coronary artery disease	0.000253	0.00213	CcSEcCtD
Levosimendan—Constipation—Enalapril—coronary artery disease	0.000253	0.00213	CcSEcCtD
Levosimendan—Tachycardia—Losartan—coronary artery disease	0.000252	0.00212	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Telmisartan—coronary artery disease	0.000252	0.00212	CcSEcCtD
Levosimendan—Hypotension—Furosemide—coronary artery disease	0.00025	0.0021	CcSEcCtD
Levosimendan—Constipation—Telmisartan—coronary artery disease	0.000249	0.0021	CcSEcCtD
Levosimendan—Insomnia—Perindopril—coronary artery disease	0.000249	0.0021	CcSEcCtD
Levosimendan—Diarrhoea—Clopidogrel—coronary artery disease	0.000249	0.0021	CcSEcCtD
Levosimendan—Mental disorder—Lisinopril—coronary artery disease	0.000248	0.00208	CcSEcCtD
Levosimendan—Diarrhoea—Lovastatin—coronary artery disease	0.000247	0.00208	CcSEcCtD
Levosimendan—Nausea—Acetylsalicylic acid—coronary artery disease	0.000246	0.00207	CcSEcCtD
Levosimendan—Malnutrition—Lisinopril—coronary artery disease	0.000246	0.00207	CcSEcCtD
Levosimendan—Dizziness—Fenofibrate—coronary artery disease	0.000245	0.00206	CcSEcCtD
Levosimendan—Diarrhoea—Ezetimibe—coronary artery disease	0.000242	0.00204	CcSEcCtD
Levosimendan—Constipation—Captopril—coronary artery disease	0.000242	0.00204	CcSEcCtD
Levosimendan—Hypotension—Losartan—coronary artery disease	0.000241	0.00203	CcSEcCtD
Levosimendan—Dizziness—Clopidogrel—coronary artery disease	0.000241	0.00202	CcSEcCtD
Levosimendan—Dizziness—Lovastatin—coronary artery disease	0.000239	0.00201	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Perindopril—coronary artery disease	0.000238	0.002	CcSEcCtD
Levosimendan—Diarrhoea—Eplerenone—coronary artery disease	0.000237	0.002	CcSEcCtD
Levosimendan—Constipation—Perindopril—coronary artery disease	0.000235	0.00198	CcSEcCtD
Levosimendan—Vomiting—Fenofibrate—coronary artery disease	0.000235	0.00198	CcSEcCtD
Levosimendan—Dizziness—Ezetimibe—coronary artery disease	0.000234	0.00197	CcSEcCtD
Levosimendan—Insomnia—Losartan—coronary artery disease	0.000233	0.00197	CcSEcCtD
Levosimendan—Headache—Fenofibrate—coronary artery disease	0.000232	0.00195	CcSEcCtD
Levosimendan—Vomiting—Clopidogrel—coronary artery disease	0.000231	0.00195	CcSEcCtD
Levosimendan—Diarrhoea—Simvastatin—coronary artery disease	0.000231	0.00195	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Furosemide—coronary artery disease	0.000231	0.00194	CcSEcCtD
Levosimendan—Vomiting—Lovastatin—coronary artery disease	0.00023	0.00193	CcSEcCtD
Levosimendan—Dizziness—Eplerenone—coronary artery disease	0.000229	0.00193	CcSEcCtD
Levosimendan—Constipation—Furosemide—coronary artery disease	0.000229	0.00193	CcSEcCtD
Levosimendan—Headache—Clopidogrel—coronary artery disease	0.000228	0.00192	CcSEcCtD
Levosimendan—Headache—Lovastatin—coronary artery disease	0.000226	0.00191	CcSEcCtD
Levosimendan—Vomiting—Ezetimibe—coronary artery disease	0.000225	0.0019	CcSEcCtD
Levosimendan—Dizziness—Simvastatin—coronary artery disease	0.000223	0.00188	CcSEcCtD
Levosimendan—Headache—Ezetimibe—coronary artery disease	0.000222	0.00187	CcSEcCtD
Levosimendan—Constipation—Losartan—coronary artery disease	0.000221	0.00186	CcSEcCtD
Levosimendan—Vomiting—Eplerenone—coronary artery disease	0.000221	0.00186	CcSEcCtD
Levosimendan—Nausea—Fenofibrate—coronary artery disease	0.00022	0.00185	CcSEcCtD
Levosimendan—Diarrhoea—Valsartan—coronary artery disease	0.000218	0.00184	CcSEcCtD
Levosimendan—Diarrhoea—Olmesartan—coronary artery disease	0.000217	0.00183	CcSEcCtD
Levosimendan—Headache—Eplerenone—coronary artery disease	0.000217	0.00183	CcSEcCtD
Levosimendan—Nervous system disorder—Ramipril—coronary artery disease	0.000217	0.00183	CcSEcCtD
Levosimendan—Nausea—Clopidogrel—coronary artery disease	0.000216	0.00182	CcSEcCtD
Levosimendan—Tachycardia—Ramipril—coronary artery disease	0.000216	0.00182	CcSEcCtD
Levosimendan—Vomiting—Simvastatin—coronary artery disease	0.000215	0.00181	CcSEcCtD
Levosimendan—Nausea—Lovastatin—coronary artery disease	0.000215	0.00181	CcSEcCtD
Levosimendan—Diarrhoea—Niacin—coronary artery disease	0.000212	0.00179	CcSEcCtD
Levosimendan—Nervous system disorder—Timolol—coronary artery disease	0.000212	0.00179	CcSEcCtD
Levosimendan—Headache—Simvastatin—coronary artery disease	0.000212	0.00178	CcSEcCtD
Levosimendan—Dizziness—Valsartan—coronary artery disease	0.000211	0.00178	CcSEcCtD
Levosimendan—Nausea—Ezetimibe—coronary artery disease	0.00021	0.00177	CcSEcCtD
Levosimendan—Dizziness—Olmesartan—coronary artery disease	0.00021	0.00177	CcSEcCtD
Levosimendan—Diarrhoea—Pravastatin—coronary artery disease	0.000209	0.00176	CcSEcCtD
Levosimendan—Hypotension—Ramipril—coronary artery disease	0.000207	0.00174	CcSEcCtD
Levosimendan—Nausea—Eplerenone—coronary artery disease	0.000206	0.00173	CcSEcCtD
Levosimendan—Dizziness—Niacin—coronary artery disease	0.000205	0.00173	CcSEcCtD
Levosimendan—Diarrhoea—Trandolapril—coronary artery disease	0.000203	0.00171	CcSEcCtD
Levosimendan—Vomiting—Valsartan—coronary artery disease	0.000203	0.00171	CcSEcCtD
Levosimendan—Diarrhoea—Enalapril—coronary artery disease	0.000202	0.0017	CcSEcCtD
Levosimendan—Hypotension—Timolol—coronary artery disease	0.000202	0.0017	CcSEcCtD
Levosimendan—Dizziness—Pravastatin—coronary artery disease	0.000202	0.0017	CcSEcCtD
Levosimendan—Vomiting—Olmesartan—coronary artery disease	0.000202	0.0017	CcSEcCtD
Levosimendan—Nausea—Simvastatin—coronary artery disease	0.000201	0.00169	CcSEcCtD
Levosimendan—Insomnia—Ramipril—coronary artery disease	0.0002	0.00169	CcSEcCtD
Levosimendan—Headache—Valsartan—coronary artery disease	0.0002	0.00168	CcSEcCtD
Levosimendan—Diarrhoea—Telmisartan—coronary artery disease	0.000199	0.00168	CcSEcCtD
Levosimendan—Headache—Olmesartan—coronary artery disease	0.000199	0.00168	CcSEcCtD
Levosimendan—Vomiting—Niacin—coronary artery disease	0.000197	0.00166	CcSEcCtD
Levosimendan—Dizziness—Trandolapril—coronary artery disease	0.000196	0.00165	CcSEcCtD
Levosimendan—Tachycardia—Lisinopril—coronary artery disease	0.000196	0.00165	CcSEcCtD
Levosimendan—Insomnia—Timolol—coronary artery disease	0.000196	0.00165	CcSEcCtD
Levosimendan—Dizziness—Enalapril—coronary artery disease	0.000195	0.00165	CcSEcCtD
Levosimendan—Headache—Niacin—coronary artery disease	0.000194	0.00164	CcSEcCtD
Levosimendan—Vomiting—Pravastatin—coronary artery disease	0.000194	0.00164	CcSEcCtD
Levosimendan—Diarrhoea—Captopril—coronary artery disease	0.000194	0.00163	CcSEcCtD
Levosimendan—Dizziness—Telmisartan—coronary artery disease	0.000193	0.00162	CcSEcCtD
Levosimendan—Headache—Pravastatin—coronary artery disease	0.000191	0.00161	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Ramipril—coronary artery disease	0.000191	0.00161	CcSEcCtD
Levosimendan—Nausea—Valsartan—coronary artery disease	0.00019	0.0016	CcSEcCtD
Levosimendan—Constipation—Ramipril—coronary artery disease	0.000189	0.00159	CcSEcCtD
Levosimendan—Nausea—Olmesartan—coronary artery disease	0.000189	0.00159	CcSEcCtD
Levosimendan—Vomiting—Trandolapril—coronary artery disease	0.000189	0.00159	CcSEcCtD
Levosimendan—Diarrhoea—Perindopril—coronary artery disease	0.000188	0.00159	CcSEcCtD
Levosimendan—Vomiting—Enalapril—coronary artery disease	0.000188	0.00158	CcSEcCtD
Levosimendan—Hypotension—Lisinopril—coronary artery disease	0.000188	0.00158	CcSEcCtD
Levosimendan—Dizziness—Captopril—coronary artery disease	0.000187	0.00158	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Timolol—coronary artery disease	0.000187	0.00157	CcSEcCtD
Levosimendan—Headache—Trandolapril—coronary artery disease	0.000186	0.00156	CcSEcCtD
Levosimendan—Vomiting—Telmisartan—coronary artery disease	0.000185	0.00156	CcSEcCtD
Levosimendan—Headache—Enalapril—coronary artery disease	0.000185	0.00156	CcSEcCtD
Levosimendan—Nausea—Niacin—coronary artery disease	0.000184	0.00155	CcSEcCtD
Levosimendan—Diarrhoea—Furosemide—coronary artery disease	0.000183	0.00154	CcSEcCtD
Levosimendan—Headache—Telmisartan—coronary artery disease	0.000183	0.00154	CcSEcCtD
Levosimendan—Dizziness—Perindopril—coronary artery disease	0.000182	0.00153	CcSEcCtD
Levosimendan—Insomnia—Lisinopril—coronary artery disease	0.000182	0.00153	CcSEcCtD
Levosimendan—Nausea—Pravastatin—coronary artery disease	0.000181	0.00153	CcSEcCtD
Levosimendan—Vomiting—Captopril—coronary artery disease	0.00018	0.00152	CcSEcCtD
Levosimendan—Headache—Captopril—coronary artery disease	0.000178	0.00149	CcSEcCtD
Levosimendan—Dizziness—Furosemide—coronary artery disease	0.000177	0.00149	CcSEcCtD
Levosimendan—Diarrhoea—Losartan—coronary artery disease	0.000177	0.00149	CcSEcCtD
Levosimendan—Nausea—Trandolapril—coronary artery disease	0.000176	0.00148	CcSEcCtD
Levosimendan—Nausea—Enalapril—coronary artery disease	0.000176	0.00148	CcSEcCtD
Levosimendan—Vomiting—Perindopril—coronary artery disease	0.000175	0.00147	CcSEcCtD
Levosimendan—Gastrointestinal disorder—Lisinopril—coronary artery disease	0.000173	0.00146	CcSEcCtD
Levosimendan—Nausea—Telmisartan—coronary artery disease	0.000173	0.00146	CcSEcCtD
Levosimendan—Headache—Perindopril—coronary artery disease	0.000172	0.00145	CcSEcCtD
Levosimendan—Constipation—Lisinopril—coronary artery disease	0.000172	0.00145	CcSEcCtD
Levosimendan—Dizziness—Losartan—coronary artery disease	0.000171	0.00144	CcSEcCtD
Levosimendan—Vomiting—Furosemide—coronary artery disease	0.00017	0.00143	CcSEcCtD
Levosimendan—Nausea—Captopril—coronary artery disease	0.000168	0.00142	CcSEcCtD
Levosimendan—Headache—Furosemide—coronary artery disease	0.000168	0.00141	CcSEcCtD
Levosimendan—Vomiting—Losartan—coronary artery disease	0.000164	0.00138	CcSEcCtD
Levosimendan—Nausea—Perindopril—coronary artery disease	0.000163	0.00138	CcSEcCtD
Levosimendan—Headache—Losartan—coronary artery disease	0.000162	0.00136	CcSEcCtD
Levosimendan—Nausea—Furosemide—coronary artery disease	0.000159	0.00134	CcSEcCtD
Levosimendan—Nausea—Losartan—coronary artery disease	0.000153	0.00129	CcSEcCtD
Levosimendan—Diarrhoea—Ramipril—coronary artery disease	0.000151	0.00127	CcSEcCtD
Levosimendan—Diarrhoea—Timolol—coronary artery disease	0.000148	0.00125	CcSEcCtD
Levosimendan—Dizziness—Ramipril—coronary artery disease	0.000146	0.00123	CcSEcCtD
Levosimendan—Dizziness—Timolol—coronary artery disease	0.000143	0.0012	CcSEcCtD
Levosimendan—Vomiting—Ramipril—coronary artery disease	0.000141	0.00118	CcSEcCtD
Levosimendan—Headache—Ramipril—coronary artery disease	0.000139	0.00117	CcSEcCtD
Levosimendan—Vomiting—Timolol—coronary artery disease	0.000138	0.00116	CcSEcCtD
Levosimendan—Diarrhoea—Lisinopril—coronary artery disease	0.000137	0.00116	CcSEcCtD
Levosimendan—Headache—Timolol—coronary artery disease	0.000136	0.00114	CcSEcCtD
Levosimendan—Dizziness—Lisinopril—coronary artery disease	0.000133	0.00112	CcSEcCtD
Levosimendan—Nausea—Ramipril—coronary artery disease	0.000131	0.00111	CcSEcCtD
Levosimendan—Nausea—Timolol—coronary artery disease	0.000129	0.00108	CcSEcCtD
Levosimendan—Vomiting—Lisinopril—coronary artery disease	0.000128	0.00107	CcSEcCtD
Levosimendan—Headache—Lisinopril—coronary artery disease	0.000126	0.00106	CcSEcCtD
Levosimendan—Nausea—Lisinopril—coronary artery disease	0.000119	0.001	CcSEcCtD
Levosimendan—PDE3A—Signaling Pathways—ADORA3—coronary artery disease	3.7e-05	0.000388	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADORA1—coronary artery disease	3.7e-05	0.000388	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA4—coronary artery disease	3.7e-05	0.000388	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PLAU—coronary artery disease	3.69e-05	0.000387	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL12—coronary artery disease	3.69e-05	0.000387	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—BDKRB2—coronary artery disease	3.69e-05	0.000387	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP11B2—coronary artery disease	3.67e-05	0.000385	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—TXNRD1—coronary artery disease	3.67e-05	0.000385	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC22A3—coronary artery disease	3.61e-05	0.000379	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PLCB1—coronary artery disease	3.61e-05	0.000378	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—APOA1—coronary artery disease	3.6e-05	0.000377	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PGF—coronary artery disease	3.57e-05	0.000374	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPBP—coronary artery disease	3.57e-05	0.000374	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDNRA—coronary artery disease	3.56e-05	0.000373	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HADH—coronary artery disease	3.56e-05	0.000373	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ARNTL—coronary artery disease	3.56e-05	0.000373	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB1—coronary artery disease	3.55e-05	0.000372	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK14—coronary artery disease	3.54e-05	0.000371	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR7—coronary artery disease	3.53e-05	0.00037	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGA2B—coronary artery disease	3.51e-05	0.000368	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DVL1—coronary artery disease	3.51e-05	0.000368	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—F2—coronary artery disease	3.43e-05	0.00036	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—FN1—coronary artery disease	3.43e-05	0.00036	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—OPRD1—coronary artery disease	3.41e-05	0.000357	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL4—coronary artery disease	3.41e-05	0.000357	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GHR—coronary artery disease	3.41e-05	0.000357	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS2—coronary artery disease	3.39e-05	0.000356	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX2—coronary artery disease	3.38e-05	0.000354	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLA2G2A—coronary artery disease	3.38e-05	0.000354	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA2—coronary artery disease	3.38e-05	0.000354	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—KNG1—coronary artery disease	3.36e-05	0.000352	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL12—coronary artery disease	3.35e-05	0.000351	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—BDKRB2—coronary artery disease	3.35e-05	0.000351	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGTR1—coronary artery disease	3.34e-05	0.00035	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCG5—coronary artery disease	3.34e-05	0.00035	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX4—coronary artery disease	3.34e-05	0.00035	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SULT1A1—coronary artery disease	3.34e-05	0.00035	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HK1—coronary artery disease	3.34e-05	0.00035	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HADHA—coronary artery disease	3.3e-05	0.000345	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PLCB1—coronary artery disease	3.28e-05	0.000343	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TLE4—coronary artery disease	3.27e-05	0.000342	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MEF2A—coronary artery disease	3.27e-05	0.000342	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL10—coronary artery disease	3.26e-05	0.000342	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTA1—coronary artery disease	3.26e-05	0.000341	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPA—coronary artery disease	3.22e-05	0.000338	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR7—coronary artery disease	3.21e-05	0.000336	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA2—coronary artery disease	3.18e-05	0.000334	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—ADRB2—coronary artery disease	3.17e-05	0.000332	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AVPR1A—coronary artery disease	3.14e-05	0.00033	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCE—coronary artery disease	3.13e-05	0.000328	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCB3—coronary artery disease	3.12e-05	0.000327	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA5—coronary artery disease	3.09e-05	0.000324	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—KNG1—coronary artery disease	3.05e-05	0.000319	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—UTS2—coronary artery disease	3.04e-05	0.000318	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGTR1—coronary artery disease	3.03e-05	0.000318	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—P4HB—coronary artery disease	3.03e-05	0.000317	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—IGF1—coronary artery disease	3.01e-05	0.000315	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLA2G1B—coronary artery disease	2.97e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NR4A1—coronary artery disease	2.97e-05	0.000312	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL10—coronary artery disease	2.96e-05	0.00031	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HDAC9—coronary artery disease	2.94e-05	0.000308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—P2RY12—coronary artery disease	2.94e-05	0.000308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLCB3—coronary artery disease	2.94e-05	0.000308	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CX3CR1—coronary artery disease	2.91e-05	0.000305	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASR—coronary artery disease	2.91e-05	0.000305	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—ADRB2—coronary artery disease	2.87e-05	0.000301	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—SERPINE1—coronary artery disease	2.86e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—P4HB—coronary artery disease	2.86e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BDKRB1—coronary artery disease	2.86e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GNA12—coronary artery disease	2.86e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CX3CL1—coronary artery disease	2.86e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—ALB—coronary artery disease	2.85e-05	0.000299	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCE—coronary artery disease	2.84e-05	0.000297	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—EDN1—coronary artery disease	2.83e-05	0.000296	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CCL5—coronary artery disease	2.81e-05	0.000294	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP3R1—coronary artery disease	2.8e-05	0.000294	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—VCAN—coronary artery disease	2.8e-05	0.000294	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDOA—coronary artery disease	2.78e-05	0.000291	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADM—coronary artery disease	2.78e-05	0.000291	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CSF2—coronary artery disease	2.76e-05	0.00029	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—NOS3—coronary artery disease	2.73e-05	0.000286	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PDE4B—coronary artery disease	2.71e-05	0.000284	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CYBB—coronary artery disease	2.71e-05	0.000284	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MMP3—coronary artery disease	2.7e-05	0.000283	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—DCN—coronary artery disease	2.7e-05	0.000283	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—JAK2—coronary artery disease	2.65e-05	0.000278	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALDH2—coronary artery disease	2.63e-05	0.000275	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—EDN1—coronary artery disease	2.57e-05	0.000269	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HBA1—coronary artery disease	2.56e-05	0.000268	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LIPC—coronary artery disease	2.56e-05	0.000268	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CYP2C19—coronary artery disease	2.56e-05	0.000268	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3C2A—coronary artery disease	2.56e-05	0.000268	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL5—coronary artery disease	2.55e-05	0.000267	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOC3—coronary artery disease	2.54e-05	0.000267	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PRKCD—coronary artery disease	2.53e-05	0.000265	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LDLR—coronary artery disease	2.53e-05	0.000265	CbGpPWpGaD
Levosimendan—KCNJ11—Neuronal System—MAPK1—coronary artery disease	2.53e-05	0.000265	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CSF2—coronary artery disease	2.51e-05	0.000263	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SLC9A1—coronary artery disease	2.5e-05	0.000262	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTT1—coronary artery disease	2.5e-05	0.000262	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCR3—coronary artery disease	2.48e-05	0.000259	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—HTR2A—coronary artery disease	2.47e-05	0.000259	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—C3—coronary artery disease	2.47e-05	0.000259	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GCLC—coronary artery disease	2.47e-05	0.000259	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CETP—coronary artery disease	2.47e-05	0.000259	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CRK—coronary artery disease	2.44e-05	0.000256	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—SDC1—coronary artery disease	2.44e-05	0.000256	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SH2B3—coronary artery disease	2.41e-05	0.000253	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ATP2A2—coronary artery disease	2.41e-05	0.000253	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VWF—coronary artery disease	2.41e-05	0.000253	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOC3—coronary artery disease	2.4e-05	0.000251	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LDLR—coronary artery disease	2.38e-05	0.00025	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AGT—coronary artery disease	2.35e-05	0.000246	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PPP2CA—coronary artery disease	2.34e-05	0.000245	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL3—coronary artery disease	2.33e-05	0.000244	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL2—coronary artery disease	2.33e-05	0.000244	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSMA6—coronary artery disease	2.31e-05	0.000242	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PSMB5—coronary artery disease	2.31e-05	0.000242	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SDC1—coronary artery disease	2.3e-05	0.000241	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2R—coronary artery disease	2.3e-05	0.000241	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PRKCD—coronary artery disease	2.3e-05	0.000241	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CTGF—coronary artery disease	2.25e-05	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGB—coronary artery disease	2.25e-05	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—HTR2A—coronary artery disease	2.25e-05	0.000236	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—C3—coronary artery disease	2.24e-05	0.000235	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GOT2—coronary artery disease	2.23e-05	0.000234	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMGCR—coronary artery disease	2.23e-05	0.000234	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRB—coronary artery disease	2.23e-05	0.000234	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—THBS1—coronary artery disease	2.2e-05	0.00023	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSMB5—coronary artery disease	2.17e-05	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PSMA6—coronary artery disease	2.17e-05	0.000228	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—F2—coronary artery disease	2.17e-05	0.000227	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AGT—coronary artery disease	2.13e-05	0.000223	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDNRA—coronary artery disease	2.11e-05	0.000221	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CYBA—coronary artery disease	2.1e-05	0.00022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB1—coronary artery disease	2.1e-05	0.00022	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—DUSP6—coronary artery disease	2.09e-05	0.000219	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PLCB1—coronary artery disease	2.05e-05	0.000215	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLAT—coronary artery disease	2.05e-05	0.000215	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ABCA1—coronary artery disease	1.99e-05	0.000209	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—BDKRB2—coronary artery disease	1.98e-05	0.000207	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL12—coronary artery disease	1.98e-05	0.000207	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—POMC—coronary artery disease	1.98e-05	0.000207	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—F2—coronary artery disease	1.97e-05	0.000206	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—VEGFA—coronary artery disease	1.96e-05	0.000206	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6ST—coronary artery disease	1.96e-05	0.000206	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JUNB—coronary artery disease	1.94e-05	0.000204	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLCB1—coronary artery disease	1.94e-05	0.000203	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GOT1—coronary artery disease	1.93e-05	0.000202	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GGT1—coronary artery disease	1.93e-05	0.000202	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR7—coronary artery disease	1.9e-05	0.000199	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGAV—coronary artery disease	1.81e-05	0.000189	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—TGFB1—coronary artery disease	1.8e-05	0.000189	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KNG1—coronary artery disease	1.8e-05	0.000189	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—POMC—coronary artery disease	1.79e-05	0.000188	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CREB1—coronary artery disease	1.79e-05	0.000188	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGTR1—coronary artery disease	1.79e-05	0.000188	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—MAPK1—coronary artery disease	1.77e-05	0.000185	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CCL2—coronary artery disease	1.76e-05	0.000184	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6R—coronary artery disease	1.75e-05	0.000183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL10—coronary artery disease	1.75e-05	0.000183	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PLG—coronary artery disease	1.74e-05	0.000183	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTP1—coronary artery disease	1.73e-05	0.000181	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARGC1A—coronary artery disease	1.72e-05	0.00018	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—HMOX1—coronary artery disease	1.71e-05	0.000179	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ADRB2—coronary artery disease	1.7e-05	0.000178	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CAT—coronary artery disease	1.68e-05	0.000177	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCE—coronary artery disease	1.68e-05	0.000176	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—JAK2—coronary artery disease	1.68e-05	0.000176	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SOCS1—coronary artery disease	1.67e-05	0.000175	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—S100B—coronary artery disease	1.67e-05	0.000175	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SOCS3—coronary artery disease	1.65e-05	0.000173	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOB—coronary artery disease	1.64e-05	0.000171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFBR2—coronary artery disease	1.63e-05	0.000171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KITLG—coronary artery disease	1.63e-05	0.000171	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—STAT5A—coronary artery disease	1.6e-05	0.000167	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP3—coronary artery disease	1.6e-05	0.000167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GSTM1—coronary artery disease	1.59e-05	0.000167	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—LPL—coronary artery disease	1.56e-05	0.000164	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOB—coronary artery disease	1.54e-05	0.000162	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—PIK3CA—coronary artery disease	1.53e-05	0.000161	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—CXCL8—coronary artery disease	1.53e-05	0.00016	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—GPX1—coronary artery disease	1.52e-05	0.00016	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—JAK2—coronary artery disease	1.52e-05	0.000159	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—EDN1—coronary artery disease	1.52e-05	0.000159	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL5—coronary artery disease	1.51e-05	0.000158	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—CD36—coronary artery disease	1.48e-05	0.000156	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CSF2—coronary artery disease	1.48e-05	0.000155	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF1—coronary artery disease	1.48e-05	0.000155	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LPL—coronary artery disease	1.47e-05	0.000154	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPP2CA—coronary artery disease	1.47e-05	0.000154	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MEF2C—coronary artery disease	1.46e-05	0.000153	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—RPS6KB1—coronary artery disease	1.46e-05	0.000153	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ITGB3—coronary artery disease	1.42e-05	0.000149	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—MTHFR—coronary artery disease	1.41e-05	0.000147	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—CXCL8—coronary artery disease	1.39e-05	0.000146	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PPP2CA—coronary artery disease	1.38e-05	0.000145	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PRKCD—coronary artery disease	1.36e-05	0.000142	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AGT—coronary artery disease	1.34e-05	0.00014	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HTR2A—coronary artery disease	1.33e-05	0.000139	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—C3—coronary artery disease	1.33e-05	0.000139	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOE—coronary artery disease	1.31e-05	0.000137	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—APOA1—coronary artery disease	1.29e-05	0.000136	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—HIF1A—coronary artery disease	1.26e-05	0.000133	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AGT—coronary artery disease	1.26e-05	0.000132	CbGpPWpGaD
Levosimendan—PDE3A—Hemostasis—AKT1—coronary artery disease	1.25e-05	0.000131	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOE—coronary artery disease	1.23e-05	0.000129	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—LEP—coronary artery disease	1.23e-05	0.000129	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—APOA1—coronary artery disease	1.22e-05	0.000128	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KDR—coronary artery disease	1.21e-05	0.000127	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK14—coronary artery disease	1.2e-05	0.000126	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—ESR1—coronary artery disease	1.18e-05	0.000123	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FN1—coronary artery disease	1.16e-05	0.000122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—F2—coronary artery disease	1.16e-05	0.000122	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6ST—coronary artery disease	1.16e-05	0.000121	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NFKBIA—coronary artery disease	1.15e-05	0.000121	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PPARG—coronary artery disease	1.14e-05	0.00012	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—POMC—coronary artery disease	1.12e-05	0.000118	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—KIT—coronary artery disease	1.11e-05	0.000117	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—GSK3B—coronary artery disease	1.07e-05	0.000112	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—POMC—coronary artery disease	1.06e-05	0.000111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CREB1—coronary artery disease	1.06e-05	0.000111	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCL2—coronary artery disease	1.04e-05	0.000109	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6R—coronary artery disease	1.03e-05	0.000108	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—ALB—coronary artery disease	1.03e-05	0.000107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IGF1—coronary artery disease	1.02e-05	0.000107	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—MAPK1—coronary artery disease	1.01e-05	0.000106	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—NOS3—coronary artery disease	9.81e-06	0.000103	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—PIK3CA—coronary artery disease	9.7e-06	0.000102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—SERPINE1—coronary artery disease	9.68e-06	0.000102	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—FGF2—coronary artery disease	9.38e-06	9.83e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—NOS3—coronary artery disease	9.25e-06	9.69e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—JAK2—coronary artery disease	8.99e-06	9.42e-05	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PTGS2—coronary artery disease	8.97e-06	9.4e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—PIK3CA—coronary artery disease	8.81e-06	9.23e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CXCL8—coronary artery disease	8.2e-06	8.6e-05	CbGpPWpGaD
Levosimendan—PDE3A—GPCR downstream signaling—AKT1—coronary artery disease	7.92e-06	8.3e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CASP3—coronary artery disease	7.85e-06	8.23e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—IL6—coronary artery disease	7.8e-06	8.17e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—CCND1—coronary artery disease	7.64e-06	8.01e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MMP9—coronary artery disease	7.42e-06	7.77e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling by GPCR—AKT1—coronary artery disease	7.19e-06	7.54e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—VEGFA—coronary artery disease	6.66e-06	6.98e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—TGFB1—coronary artery disease	6.11e-06	6.41e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—MAPK1—coronary artery disease	6e-06	6.28e-05	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—PIK3CA—coronary artery disease	5.52e-06	5.78e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—PIK3CA—coronary artery disease	5.2e-06	5.45e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—IL6—coronary artery disease	4.61e-06	4.83e-05	CbGpPWpGaD
Levosimendan—KCNJ11—Metabolism—AKT1—coronary artery disease	4.51e-06	4.72e-05	CbGpPWpGaD
Levosimendan—PDE3A—Signaling Pathways—AKT1—coronary artery disease	4.25e-06	4.45e-05	CbGpPWpGaD
